January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

In people with PA and no concerning features, treatment with high-dose oral B12 or injection B12 are both reasonable options. However, people with severe anemia or neuropsychiatric symptoms (like the ...

A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a clinical-stage biotech company with a market capitalization of $28 million, announced today positive outcomes from its Phase 1 ...